Structure-based de novo design, synthesis, and biological evaluation of the indole-based PPARγ ligands (I)

被引：12
|
作者：
Dong, Xiaochun
Zhang, Zhenshan
Wen, Ren [1 ]
Shen, Jianhua
Shen, Xu
Jiang, Hualiang
机构：
[1] Fudan Univ, Dept Med Chem, Shanghai 200032, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 22期
关键词：
de novo drug design; PPAR gamma ligand; type II diabetes; indole compounds;
D O I：
10.1016/j.bmcl.2006.06.093
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
MCSS and LeapFrog, two de novo drug design programs, were used for the novel indole-based PPAR gamma ligands' study. The designed compounds were synthesized and tested for the PPAR gamma protein binding activities in vitro. Out of the compounds that were synthesized, two molecules (compounds 14d and 7d) possessed potent PPAR gamma protein binding activity close to rosiglitazone in vitro. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5913 / 5916
页数：4
相关论文
共 50 条
  • [31] Structure-based identification of novel PPAR gamma ligands
    da Silva, Flavia M. C.
    dos Santos, Jademilson C.
    Campos, Jessica L. O.
    Mafud, Ana Carolina
    Polikarpov, Igor
    Figueira, Ana Carolina M.
    Nascimento, Alessandro S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (21) : 5795 - 5802
  • [32] De Novo Structure-Based Drug Design Using Deep Learning
    Krishnan, Sowmya Ramaswamy
    Bung, Navneet
    Vangala, Sarveswara Rao
    Srinivasan, Rajgopal
    Bulusu, Gopalakrishnan
    Roy, Arijit
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2022, 62 (21) : 5100 - 5109
  • [33] De novo structure-based design of high symmetry coordination clusters
    Hay, Benjamin P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 980 - 980
  • [34] ENPDA:: an evolutionary structure-based de novo peptide design algorithm
    Belda, I
    Madurga, S
    Llorà, X
    Martinell, M
    Tarragó, T
    Piqueras, MG
    Nicolás, E
    Giralt, E
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2005, 19 (08) : 585 - 601
  • [35] SkelGen: a general tool for structure-based de novo ligand design
    Dean, Philip M.
    Firth-Clark, Stuart
    Harris, William
    Kirton, Stewart B.
    Todorov, Nikolay P.
    EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (02) : 179 - 189
  • [36] Structure-based discovery and de novo design of HIV fusion inhibitors
    Allen, William
    Rizzo, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [37] Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents.
    Hsieh, HP
    Mahindroo, N
    Wang, CC
    Huang, CF
    Lien, TW
    Tsai, CH
    Peng, YH
    Lee, LH
    Prakash, E
    Chen, WC
    Chang, YW
    Hsu, TA
    Chen, X
    Wu, SY
    Chen, CT
    Lan, SJ
    Chao, YS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U141 - U141
  • [38] De novo structure-based design of factor XA inhibitors.
    Cheney, DL
    Mason, JS
    Becker, MR
    Ewing, RW
    Pauls, HW
    Todorov, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U861 - U861
  • [39] Structure-based De novo design of estrone sulfatase inhibitors.
    Ghosh, D
    Ghosh, D
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9052S - 9052S
  • [40] Recent Advances in Automated Structure-Based De Novo Drug Design
    Tang, Yidan
    Moretti, Rocco
    Meiler, Jens
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (06) : 1794 - 1805
12345